In less than a decade, Prenetics Group Ltd. transformed itself from a DNA-kit maker to a major Hong Kong Covid-19 test provider. Now as the coronavirus ebbs in the city — and the rest of the world adjusts to living with it — Chief Executive Officer Danny Yeung is already planning its next pivot.